Performance Merlin Assay confirmed in independent US validation cohort News provided by Share this article Share this article ROTTERDAM, Netherlands and SAN DIEGO, April 30, 2021 /PRNewswire/ -- SkylineDx announced that the performance of their melanoma diagnostic test (Merlin Assay) is confirmed in an independent group of U.S. patients from the Mayo Clinic and West Virginia University [1]. All newly diagnosed primary cutaneous melanoma patients in this cohort were referred to undergo the sentinel lymph node biopsy (SLNB) procedure. This is a surgical procedure under general anesthetics tha...